The Boston biotech Aera Therapeutics said on Thursday it had raised $193 million. Feng Zhang, Aera's founder and a CRISPR pioneer, spoke with Insider about his vision for the firm. Aera wants to ...

Aera Therapeutics, a startup launched by the CRISPR pioneer Feng Zhang last year to solve one of the biggest bottlenecks in genetic medicine, has laid off a quarter of its staff, the company ...

A new startup co-founded by CRISPR innovator Feng Zhang, a former executive at Grail and Illumina, and others has raised $57 million to develop a defanged form of gene editing that doesn’t cut ...

Aera Therapeutics is launching with $193 million to develop a new nanoparticle technology to deliver genetic medicines to hard-to-reach parts of the body. Months before Feng Zhang met with a trio ...

Akin Akinc was scouring his email spam box last summer, looking for a missing message, when he stumbled across an unexpected email from a quite recognizable name: Feng Zhang. Zhang, one of the ...

At the Broad Institute of MIT and Harvard and the McGovern Institute for Brain Research at MIT, Dr. Feng Zhang discovers and develops gene-editing systems that can be harnessed as research tools and ...